Cargando…
An adaptable in vitro cytokine release assay (CRA): Susceptibility to cytokine storm in COVID-19 as a model
Translational in vitro models such as cytokine release assay (CRA) are essential to assess the susceptibility to cytokine storm or CRS in a non-interventional manner in a human in vitro laboratory setting. Such models are also helpful to unravel disease mechanisms, to study the effects of new therap...
Autores principales: | Alam, Masih, Choudhury, Rawshan, Lamers, Robert-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682056/ https://www.ncbi.nlm.nih.gov/pubmed/36440186 http://dx.doi.org/10.1016/j.crimmu.2022.11.001 |
Ejemplares similares
-
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine
por: Baldelli, Luca, et al.
Publicado: (2021) -
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2
por: Bahoosh, Saba Rahimi, et al.
Publicado: (2022) -
Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials — Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm
por: Vessillier, S., et al.
Publicado: (2015) -
Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak
por: Griffin, Daniel O., et al.
Publicado: (2021) -
Trypsin may induce cytokine storm in M1 macrophages, resulting in critical coronavirus disease
por: Chen, Hongyu, et al.
Publicado: (2022)